dr. lynch on targeting egfr mutation subtypes in lung cancer
Published 8 years ago • 340 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
2:10
dr. lynch accepts his "giants of cancer care" award
-
5:02
egfr-mutant lung cancer: initial approach
-
5:50
targeted therapy in egfr exon 20-mutant non–small cell lung cancer
-
1:06
dr. goldman on targeted therapy options for egfr-, alk-, and ros1-mutated nsclc
-
4:51
understanding egfr-mutant nsclc subsets
-
0:42
dr. fidler discusses osimertinib in egfr-mutated lung cancer
-
1:37
dr. yu on treatments for egfr-mutant lung cancer
-
3:29
burden of egfr exon 20 mutation in nsclc
-
1:57
dr. piotrowska on treatment for egfr-mutant nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
6:12
resistance in egfr-mutant lung cancer
-
1:16
dr. wakelee on first-line therapy for egfr-mutant lung cancer
-
2:02
evolutions in the treatment of egfr-mutated nsclc
-
6:56
first-line therapy in the patient with egfr-mutant lung cancer
-
4:09
frontline afatinib in egfr-mutant nsclc
-
3:24
sequencing of therapies in egfr-mutant nsclc
-
1:15
dr. aggarwal on triplet therapy in egfr-mutant lung cancer
-
1:07
dr. garassino on immunotherapy in egfr-mutated lung cancer
-
5:00
options for up-front therapy in egfr-mutant nsclc